Correlation Between Gold Ent and Ventana Biotech

Can any of the company-specific risk be diversified away by investing in both Gold Ent and Ventana Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gold Ent and Ventana Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gold Ent Group and Ventana Biotech, you can compare the effects of market volatilities on Gold Ent and Ventana Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gold Ent with a short position of Ventana Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gold Ent and Ventana Biotech.

Diversification Opportunities for Gold Ent and Ventana Biotech

-0.19

Correlation Coefficient

Gold Ent  Ventana Biotech

Good diversification

The 3 months correlation between Gold and Ventana is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Gold Ent Group and Ventana Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventana Biotech and Gold Ent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gold Ent Group are associated (or correlated) with Ventana Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventana Biotech has no effect on the direction of Gold Ent i.e., Gold Ent and Ventana Biotech go up and down completely randomly.

Pair Corralation between Gold Ent and Ventana Biotech

Given the investment horizon of 90 days Gold Ent is expected to generate 2.88 times less return on investment than Ventana Biotech. But when comparing it to its historical volatility, Gold Ent Group is 1.57 times less risky than Ventana Biotech. It trades about 0.13 of its potential returns per unit of risk. Ventana Biotech is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  0.04  in Ventana Biotech on September 16, 2024 and sell it today you would earn a total of  0.10  from holding Ventana Biotech or generate 250.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Gold Ent Group  vs.  Ventana Biotech

Gold Ent Group

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Gold Ent Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Gold Ent reported solid returns over the last few months and may actually be approaching a breakup point.

Ventana Biotech

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ventana Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Ventana Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Gold Ent and Ventana Biotech

The main advantage of trading using opposite Gold Ent and Ventana Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gold Ent position performs unexpectedly, Ventana Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will offset losses from the drop in Ventana Biotech's long position.

The idea behind Gold Ent Group and Ventana Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.